As of March 2025 Nektar Therapeutics has a market cap of A$0.22 Billion. This makes Nektar Therapeutics the world's 8655th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$0.22 B | -20.49% |
2024 | A$0.28 B | 77.93% |
2023 | A$0.15 B | -74.65% |
2022 | A$0.62 B | -81.85% |
2021 | A$3.43 B | -13.29% |
2020 | A$3.96 B | -27.11% |
2019 | A$5.44 B | -32.79% |
2018 | A$8.09 B | -32.78% |
2017 | A$12.04 B | 363.01% |
2016 | A$2.60 B | -16.86% |
2015 | A$3.12 B | 25.92% |
2014 | A$2.48 B | 67.65% |
2013 | A$1.48 B | 80.36% |
2012 | A$0.82 B | 31.63% |
2011 | A$0.62 B | -47.78% |
2010 | A$1.19 B | 23.55% |
2009 | A$0.96 B | 32.84% |
2008 | A$0.72 B | 2.84% |
2007 | A$0.70 B | -59.78% |
2006 | A$1.76 B | -10.73% |
2005 | A$1.97 B | -10.8% |
2004 | A$2.21 B | 114.97% |
2003 | A$1.02 B | 29.15% |
2002 | A$0.79 B | -60.21% |
2001 | A$2.00 B | -53.2% |
2000 | A$4.27 B | 283.49% |
1999 | A$1.11 B | 22.33% |
1998 | A$0.91 B | 47.06% |
1997 | A$0.62 B | 175.24% |
1996 | A$0.22 B |
On Mar 26th, 2025 the market cap of Nektar Therapeutics was reported to be: